Plenary Session IV - Maintaining Access: The Future Economic Viability of Neuromodulation Featured

1:30-3:30 PM Saturday, Jan. 14

Neuromodulation is an effective treatment with a solid safety and efficacy record for multiple medical conditions. However, recently more attention has been placed on the economics of neuromodulation and the high upfront costs of the equipment; especially, in an environment of rising healthcare costs with significant patient cost-sharing. For patient therapy access to be maintained, it is important for healthcare providers and payers to understand the current cost-effectiveness data surrounding the treatment. Furthermore, physicians, manufacturers, payers, and organizational leadership will need to partner to maintain the economic viability of this technology in different sites of service. This session will provide an economic evaluation of the utilization of neuromodulation. Furthermore, techniques to enhance the economic viability will be discussed for different sites of service and selected equipment including rechargeable and non-rechargeable batteries.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Characterize methods of economic evaluation for neuromodulation.
  • Define current data surrounding the cost-effectiveness of neuromodulation.
  • Analyze methods to optimize economic viability in different sites of service including Ambulatory Surgical Centers (ASCs) and hospital outpatient departments (HOPDS).
  • Define future economic and clinical data needed to maintain therapy access.

Introduction of Keynote Speaker

Ahmed Raslan, MD

Keynote Speaker: Strategy of Creating Value in Neuromodulation

Robert S. Kaplan, PhD

Discussion with the Payers: Cost-Effectiveness of Neurostimulation for the Treatment of Pain

David A. Provenzano, MD

ASC Economics-Developing a Viable Neuromodulation Program in the ASC Setting

Damean W. Freas, DO

HOPD Economics – Developing a Viable Neuromodulation Program in the Hospital Setting

Joshua M. Rosenow, MD FACS

Economics of Brain Neuromodulation (RNS, VNS, DBS)

Rushna Ali, MD

Faculty subject to change.

Faculty:

Ahmed Raslan, MD

Robert S. Kaplan, PhD

David A. Provenzano, MD

Damean W. Freas, DO

Joshua M. Rosenow

Rushna Ali, MD

Moderators:

David A. Provenzano, MD

Joshua M. Rosenow, MD FACS

Ahmed Raslan, MD